Redx Pharma Plc (REDX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Redx Pharma Plc (REDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8193
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Redx Pharma Plc (Redx Pharma), formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics. The company’s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza and hepatitis B. Its proprietary redox switch is employed to generate novel antiviral and antibacterial drugs in the region of infectious disease. Redx Pharma’s redox switch is also used for delivering multiple development candidates over mechanistic approaches in the treatment of cancer. The company conducts research through its facilities in the UK. Redx Pharma is headquartered in Macclesfield, the UK.

Redx Pharma Plc (REDX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Redx Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Redx Pharma Acquires ROCK Inhibitor AMA0825 from Amakem 11
Partnerships 12
Horizon Discovery Enters into Research Agreement with Redx Pharma 12
Astrazeneca Enters into Research Agreement with Redx Pharma 13
Redx Pharma Enters into Research Agreement with Pierre Fabre Labs 14
Licensing Agreements 15
Deinove Enters into Option and Licensing Agreement with Redx Pharma 15
Redx Pharma Enters Into Licensing Agreement With Pharmascience For Cancer Program 16
Dotmatics Enters Into Licensing Agreement With Redx Pharma 17
Redx Pharma Enters Into Licensing Agreement With Dishman For Prescription Drug Technology 18
Equity Offering 19
Redx Pharma to Raise USD15 Million in Private Placement of Shares 19
Redx Pharma to Raise USD3.6 Million in Rights Offering of Shares 21
Redx Pharma Raises USD14.2 Million in Private Placement of Shares 22
Redx Pharma Raises USD22.7 Million in IPO 23
Asset Transactions 24
Loxo Oncology Acquires BTK Inhibitor Program from Redx Pharma 24
Redx Pharma Plc – Key Competitors 25
Redx Pharma Plc – Key Employees 26
Redx Pharma Plc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
May 30, 2018: Redx Pharma: Interim results for the six months ended 31 March 2018 28
Dec 20, 2017: Redx Pharma: Final Results for the Year Ended 30 September 2017 31
May 17, 2017: Redx Pharma: Interim Results for the six months ended 31 March 2017 33
Mar 21, 2017: Redx Pharma Announces Final results for the year ended 30 September 2016 34
Corporate Communications 35
Jun 04, 2018: REDX PHARMA: Directorate Update 35
Jun 04, 2018: Redx Pharma Appoints Lisa Anson As Chief Executive Officer 36
Aug 14, 2017: Redx announces the resignation of Non-Executive Director David Lawrence 37
Apr 20, 2017: Redx Pharma: Appointment of Chairman 38
Legal and Regulatory 39
Oct 27, 2017: Redx Pharma: Update on Application to the High Court 39
Government and Public Interest 40
Mar 30, 2017: Redx Pharma awarded US$1 million grant by CARB-X 40
Product News 41
08/31/2017: Redx to present new scientific data at ESMO 2017 41
06/23/2017: Redx announces MHRA approval of its Clinical Trial Application for Porcupine Inhibitor RXC004 42
01/27/2017: Redx outlines growing opportunity for Porcupine inhibitors 43
01/22/2018: Redx Pharma Announces Appointment of Experienced Drug Development Clinician as Chief Medical Officer 44
Clinical Trials 45
Jan 22, 2018: Redx Pharma appoints chief medical officer who will oversee launch of phase I clinical trial of new cancer drug 45
Other Significant Developments 46
Nov 06, 2017: Redx Provides a Strategic Update and Announces that Trading is to recommence in its Shares 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Redx Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Redx Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Redx Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Redx Pharma Acquires ROCK Inhibitor AMA0825 from Amakem 11
Horizon Discovery Enters into Research Agreement with Redx Pharma 12
Astrazeneca Enters into Research Agreement with Redx Pharma 13
Redx Pharma Enters into Research Agreement with Pierre Fabre Labs 14
Deinove Enters into Option and Licensing Agreement with Redx Pharma 15
Redx Pharma Enters Into Licensing Agreement With Pharmascience For Cancer Program 16
Dotmatics Enters Into Licensing Agreement With Redx Pharma 17
Redx Pharma Enters Into Licensing Agreement With Dishman For Prescription Drug Technology 18
Redx Pharma to Raise USD15 Million in Private Placement of Shares 19
Redx Pharma to Raise USD3.6 Million in Rights Offering of Shares 21
Redx Pharma Raises USD14.2 Million in Private Placement of Shares 22
Redx Pharma Raises USD22.7 Million in IPO 23
Loxo Oncology Acquires BTK Inhibitor Program from Redx Pharma 24
Redx Pharma Plc, Key Competitors 25
Redx Pharma Plc, Key Employees 26
Redx Pharma Plc, Subsidiaries 27

List of Figures
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Redx Pharma Plc (REDX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seacoast Banking Corporation of Florida:企業の戦略・SWOT・財務情報
    Seacoast Banking Corporation of Florida - Strategy, SWOT and Corporate Finance Report Summary Seacoast Banking Corporation of Florida - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Telefonaktiebolaget LM Ericsson:企業の戦略・SWOT・財務情報
    Telefonaktiebolaget LM Ericsson - Strategy, SWOT and Corporate Finance Report Summary Telefonaktiebolaget LM Ericsson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Panera Bread Company:企業の戦略的SWOT分析
    Panera Bread Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Italgas SpA-石油・ガス分野:企業M&A・提携分析
    Summary Italgas SpA (Italgas), a subsidiary of Snam SpA, is an oilfield service company that offers transportation and dispatching of natural gas, liquefied natural gas regasification, and storage and distribution of natural gas. The company's activities include rhino-analytical tests; instrumental …
  • ImpediMed Ltd (IPD):企業の財務・戦略的SWOT分析
    ImpediMed Ltd (IPD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Billabong International Limited:企業のM&A・事業提携・投資動向
    Billabong International Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Billabong International Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • PDS Biotechnology Corp-製薬・医療分野:企業M&A・提携分析
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops immunotherapies and vaccines for cancer and infectious disease. The company uses versamune technology, which is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothe …
  • Avenue Supermarts Limited (DMART):企業の財務・戦略的SWOT分析
    Avenue Supermarts Limited (DMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Aohata Corporation:企業の戦略・SWOT・財務情報
    Aohata Corporation - Strategy, SWOT and Corporate Finance Report Summary Aohata Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Coats Group plc:戦略・SWOT・企業財務分析
    Coats Group plc - Strategy, SWOT and Corporate Finance Report Summary Coats Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pro Mach, Inc.:戦略・SWOT・企業財務分析
    Pro Mach, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pro Mach, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nanyang Technological University:企業の戦略的SWOT分析
    Nanyang Technological University - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Fuji Oil Co Ltd (5017):企業の財務・戦略的SWOT分析
    Fuji Oil Co Ltd (5017) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • EQUATE Petrochemical Co:企業の戦略的SWOT分析
    EQUATE Petrochemical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Allianz Global Assistance SAS:企業の戦略・SWOT・財務情報
    Allianz Global Assistance SAS - Strategy, SWOT and Corporate Finance Report Summary Allianz Global Assistance SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cabot Microelectronics Corp (CCMP):企業の財務・戦略的SWOT分析
    Cabot Microelectronics Corp (CCMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Broncus Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Broncus Medical Inc (Broncus), formerly Broncus Technologies Inc is a medical device company that develops navigation, diagnostic and therapeutic technologies. The company’s products comprise lungpoint virtual bronchoscopic navigation system, lungpoint satellite planning system, and flexneed …
  • MabVax Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary MabVax Therapeutics Inc (MabVax Therapeutics), a subsidiary of MabVax Therapeutics Holdings Inc is a biopharmaceutical company that develops and commercializes anti-cancer immunotherapies from antibody and vaccine technology. The company offers immune-oncology technology platforms such as hu …
  • Marshall Aerospace and Defence Group:戦略・SWOT・企業財務分析
    Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report Summary Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析
    New Zealand Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆